These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 19560901

  • 21. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
    Hofer A, Bodner T, Kaufmann A, Kemmler G, Mattarei U, Pfaffenberger NM, Rettenbacher MA, Trebo E, Yalcin N, Fleischhacker WW.
    Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C, Roesch-Ely D, Veckenstedt R, Bohn F, Aghotor J, Köther U, Pfueller U, Moritz S.
    Psychiatry Res; 2013 Dec 30; 210(3):729-34. PubMed ID: 23998362
    [Abstract] [Full Text] [Related]

  • 25. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG, Risperidone Long-Acting Trial Investigators (R-LAI).
    Hum Psychopharmacol; 2009 Oct 30; 24(7):574-83. PubMed ID: 19790173
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
    Jäger M, Riedel M, Obermeier M, Schennach-Wolff R, Seemüller F, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, Gastpar M, Bottlender R, Möller HJ.
    Schizophr Res; 2010 May 30; 118(1-3):183-8. PubMed ID: 20181461
    [Abstract] [Full Text] [Related]

  • 28. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D, Del Rey-Mejías A, Moreno C, Castro-Fornieles J, Graell M, Otero S, Gonzalez-Pinto A, Moreno D, Baeza I, Martínez-Cengotitabengoa M, Arango C, Parellada M.
    Schizophr Res; 2014 Jan 30; 152(1):130-8. PubMed ID: 24332406
    [Abstract] [Full Text] [Related]

  • 29. Patient-based and clinician-based support for the remission criteria in schizophrenia.
    Docherty JP, Bossie CA, Lachaux B, Bouhours P, Zhu Y, Lasser R, Gharabawi GM.
    Int Clin Psychopharmacol; 2007 Jan 30; 22(1):51-5. PubMed ID: 17159460
    [Abstract] [Full Text] [Related]

  • 30. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 30; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.
    Lasser RA, Bossie CA, Gharabawi GM, Kane JM.
    Schizophr Res; 2005 Sep 15; 77(2-3):215-27. PubMed ID: 15908183
    [Abstract] [Full Text] [Related]

  • 34. Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
    Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Riedel M, Bottlender R, Strauss A, Möller HJ.
    Pharmacopsychiatry; 2008 Sep 15; 41(5):190-5. PubMed ID: 18763221
    [Abstract] [Full Text] [Related]

  • 35. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
    Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R.
    World J Biol Psychiatry; 2012 Jan 15; 13(1):30-8. PubMed ID: 21568628
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Symptomatic and functional remission in patients with first-episode psychosis.
    Verma S, Subramaniam M, Abdin E, Poon LY, Chong SA.
    Acta Psychiatr Scand; 2012 Oct 15; 126(4):282-9. PubMed ID: 22616617
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.